Product
Help
Pricing
About
Jobs
Log in
Get started
Award
Add to collection
CA148112
Funder:
National Cancer Institute
Funded outputs count:
91
Funder award ID:
CA148112
OpenAlex ID:
G3918072604
Circulating Inflammatory Markers and Mammographic Density Phenotypes: a Mendelian Randomization Analysis
2026
·
Austin Hammermeister Suger
, Tabitha A. Harrison
, et al.
·
medRxiv
PRANA: A Deep Learning Method for Adapting Polygenic Risk Scores to Diverse Ethnic Groups
2026
·
Hagai Levi
, Qin Wang
, et al.
·
medRxiv
PDF
Differences in overall survival for invasive epithelial ovarian cancer by race and ethnicity: results from the Ovarian Cancer Association Consortium
2026
·
Nicola S. Meagher
, Kami K. White
, et al.
·
British Journal of Cancer
PDF
Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS study
2026
·
Jason L. Vassy
, Anna M. Dornisch
, et al.
·
Nature Cancer
·
8
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer
2025
·
Daniel R. Barnes
, Jonathan P. Tyrer
, et al.
·
npj Genomic Medicine
·
1
PDF
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer
2025
·
Barnes, Daniel R
, Tyrer, Jonathan P
, et al.
·
eScholarship (California Digital Library)
PDF
GWAS meta-analysis identifies five susceptibility loci for endometrial cancer
2025
·
Dhanya Ramachandran
, Xuemin Wang
, et al.
·
EBioMedicine
·
4
PDF
Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer
2025
·
Reiner Hoppe
, Stefan Winter
, et al.
·
npj Breast Cancer
·
1
PDF
Phenome-wide Mendelian randomisation analysis of 378,142 cases reveals risk factors for eight common cancers
2024
·
Molly Went
, Amit Sud
, et al.
·
Nature Communications
·
28
PDF
Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease
2024
·
Dhanya Ramachandran
, Jonathan P. Tyrer
, et al.
·
npj Genomic Medicine
·
5
PDF
Polymorphisms in genes of melatonin biosynthesis and signaling support the light-at-night hypothesis for breast cancer
2023
·
Katharina Wichert
, Reiner Hoppe
, et al.
·
European Journal of Epidemiology
·
8
PDF
A Likelihood Ratio Approach for Utilizing Case-Control Data in the Clinical Classification of Rare Sequence Variants: Application to BRCA1 and BRCA2
2023
·
Maria Zanti
, Denise G. O'Mahony
, et al.
·
Human Mutation
·
6
Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel
2023
·
Hagai Levi
, Shai Carmi
, et al.
·
Journal of Medical Genetics
·
4
PDF
Association of the CHEK2 c. 1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer‐specific survival
2023
·
Anna Morra
, Maartje A. C. Schreurs
, et al.
·
Cancer Medicine
·
11
PDF
Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry
2023
·
Stefanie H. Mueller
, Alvina G. Lai
, et al.
·
Genome Medicine
·
15
PDF
Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival
2023
·
Josephine M.N. Lopes Cardozo
, Irene L. Andrulis
, et al.
·
Journal of Clinical Oncology
·
29
PDF
Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery
2022
·
Minh Tung Phung
, Penelope M. Webb
, et al.
·
Gynecologic Oncology
·
2
Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci
2022
·
Amber A DeVries
, Joe Dennis
, et al.
·
JNCI Journal of the National Cancer Institute
·
13
PDF
Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers
2022
·
Christopher Hakkaart
, John F. Pearson
, et al.
·
Communications Biology
·
14
PDF
CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer—A Multicenter Analysis
2022
·
Christoph Wohlmuth
, Vladimir Djedovic
, et al.
·
Cancers
·
13
PDF
Assessing the causal role of epigenetic clocks in the development of multiple cancers: a Mendelian randomization study
2022
·
Fernanda Morales-Berstein
, Daniel L McCartney
, et al.
·
eLife
·
86
Body Shape Phenotypes And Breast Cancer Risk: A Mendelian Randomization Analysis.
2022
·
Laia Peruchet Noray
, Niki Dimou
, et al.
·
Research Square
PDF
Rare germline copy number variants (CNVs) and breast cancer risk
2022
·
Joe Dennis
, Jonathan P. Tyrer
, et al.
·
Communications Biology
·
15
PDF
Common variants in breast cancer risk loci predispose to distinct tumor subtypes
2022
·
Thomas U. Ahearn
, Haoyu Zhang
, et al.
·
Breast Cancer Research
·
33
PDF
High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival
2021
·
Katharine K. Brieger
, Minh Tung Phung
, et al.
·
Cancer Epidemiology Biomarkers & Prevention
·
9
PDF
Show more works
View as search
Year
Topic